{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 1.5075363, "regularMarketPrice": 2.02, "earningsTimestamp": 1684236600, "earningsTimestampStart": 1684236600, "earningsTimestampEnd": 1684236600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.85, "sharesOutstanding": 11152700, "bookValue": 1.578, "fiftyDayAverage": 2.473, "fiftyDayAverageChange": -0.45300007, "fiftyDayAverageChangePercent": -0.18317835, "twoHundredDayAverage": 4.1589923, "twoHundredDayAverageChange": -2.1389923, "twoHundredDayAverageChangePercent": -0.5143054, "marketCap": 22528454, "priceToBook": 1.2801014, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1198825200000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "PALATIN TECHS  DL-,01", "longName": "Palatin Technologies, Inc.", "messageBoardId": "finmb_32651", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": 0.029999971, "regularMarketTime": 1683872401, "regularMarketDayHigh": 2.02, "regularMarketDayRange": "2.02 - 2.02", "regularMarketDayLow": 2.02, "regularMarketVolume": 900, "regularMarketPreviousClose": 1.99, "bid": 2.04, "ask": 2.1, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 2.02, "averageDailyVolume3Month": 742, "averageDailyVolume10Day": 940, "fiftyTwoWeekLowChange": 1.8396, "fiftyTwoWeekLowChangePercent": 10.197339, "fiftyTwoWeekRange": "0.1804 - 9.5975", "fiftyTwoWeekHighChange": -7.5775, "fiftyTwoWeekHighChangePercent": -0.78952855, "fiftyTwoWeekLow": 0.1804, "fiftyTwoWeekHigh": 9.5975, "symbol": "PTN.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Cedar Brook Corporate Center", "address2": "4-B Cedar Brook Drive", "city": "Cranbury", "state": "NJ", "zip": "08512", "country": "United States", "phone": "609 495 2200", "fax": "609 495 2202", "website": "https://palatin.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a peptide mimetic molecule with amino acid mimetic structure and amino acids properties; and L8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.", "fullTimeEmployees": 33, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl  Spana Ph.D.", "age": 60, "title": "Co-Founder, Pres, CEO & Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 943250, "fmt": "943.25k", "longFmt": "943,250"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen T. Wills CPA, CPA, MST", "age": 65, "title": "CFO, COO, Exec. VP, Treasurer & Sec.", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 870574, "fmt": "870.57k", "longFmt": "870,574"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Burns  McClellan", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen A. Slusher Esq.", "title": "Chief Legal Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael B. Raizman M.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. James E. Hattersley", "age": 62, "title": "Sr. VP of Bus. Devel.", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Dodd Ph.D.", "title": "Sr. VP of Preclinical Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert  Jordan", "title": "Sr. VP of Program Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}